Indutrade expands in med-technology

Indutrade's subsidiary has signed an agreement with Sefo Consulting AB on the acquisition of its optics products business, with annual sales of approximately SEK 6 million.

The business revolves around instruments, products and service for opticians, oculists and ophthalmic clinics. The products come from leading Japanese, American and European manufacturers. After the acquisition of EssMed AB and Brinch AS this is Indutrade’s third acquisition in the med-technology segment. Organisationally the business will be part of the Industrial Components business area, which had net sales of SEK 1,401 million in 2008. The acquisition is expected to have a marginally positive impact on Indutrade's earnings per share. Stockholm, 5 October 2009 INDUTRADE AB (publ) For further information, please contact: Johnny Alvarsson, President and CEO, tel. +46 70 589 17 95.

About Us

Indutrade markets and sells components, systems and services with a high-tech content in selected niches. The business has two main focuses - companies engaged in industrial technology sales and companies that manufacture their own products. The Group's fundamental governing principle is based on decentralisation of decision-making and responsibility. The organisation is distinguised by entrepreneurship and technical niche expertise combined with a well-balanced spread of risk with respect to customers, products, suppliers, industries and geographic markets. Indutrade is organised into eight business areas; – Benelux– DACH– Finland– Flow Technology– Fluids & Mechanical Solutions– Industrial Components– Measurement & Sensor Technology– UK Indutrade’s sales totalled SEK 14,847 million in 2017, generating operating income of SEK 1,613 million before depreciation of intangible assets. Indutrade is listed on Nasdaq Stockholm.


Documents & Links